Intelis Capital

Rhizome operates an AI-driven climate resilience platform that assists electric utilities in assessing climate risks with high precision. The platform quantifies the economic and social impacts of infrastructure investments aimed at bolstering climate resilience for both communities and businesses. By identifying vulnerabilities to climate threats and measuring the benefits of grid-enhancing projects, Rhizome enables its clients to mitigate the costs associated with damage and recovery from extreme weather events. Additionally, the platform supports clients in justifying public projects to policymakers, potentially increasing local infrastructure spending and enhancing access to federal grant funding. Through its innovative solutions, Rhizome aims to protect communities and businesses from the increasing challenges posed by climate change.

Dynamhex operates an emission monitoring platform that provides detailed insights into energy consumption data for individuals, corporations, and government entities. The platform enables users to measure their emission footprints and develop effective reduction strategies aligned with science-based targets. By employing geospatial analytics and advanced visualization techniques, Dynamhex helps city governments and businesses make informed, environmentally responsible decisions. This functionality supports climate leaders in their efforts to combat climate change by facilitating timely and data-driven decision-making.

Geosite Inc. is a company that develops a cloud-based platform for managing and utilizing geospatial data, including satellite imagery and drone mapping. Established in 2018 and headquartered in Palo Alto, California, the platform enables users to access high-frequency satellite data, planning tools, and sensor system integrations. It serves various sectors, including energy, defense, and technology, providing tools for incident management and operational workflows. Geosite's offerings include a marketplace for decision-grade spatial imagery, catering to clients such as the United States military and organizations in the energy sector.

Amperon is a provider of forecasting and analytics solutions that harness real-time energy data to deliver precise electricity demand forecasts. With over 70 million smart meters installed across the country, the company capitalizes on previously untapped data by utilizing artificial intelligence to analyze 15-minute resolution electricity consumption for residential, commercial, and industrial ratepayers. This innovative approach enables energy suppliers and utilities to manage energy costs more efficiently, contributing to the advancement of a smarter energy grid.

WNDYR specializes in digital transformation, focusing on the intersection of people and technology to enhance organizational efficiency. The company offers a human-centered platform aimed at improving customer success, work management, and change management. By prioritizing process design, platform integration, and automation, WNDYR helps organizations streamline their operations, allowing employees to concentrate on high-value tasks. The team consists of Adobe-certified experts who provide software implementation and optimization services, particularly around Workfront and Adobe Experience Manager. WNDYR serves a diverse range of industries, including healthcare and marketing, with a commitment to delivering impactful, lasting change while fostering a positive employee experience.

WNDYR specializes in digital transformation, focusing on the intersection of people and technology to enhance organizational efficiency. The company offers a human-centered platform aimed at improving customer success, work management, and change management. By prioritizing process design, platform integration, and automation, WNDYR helps organizations streamline their operations, allowing employees to concentrate on high-value tasks. The team consists of Adobe-certified experts who provide software implementation and optimization services, particularly around Workfront and Adobe Experience Manager. WNDYR serves a diverse range of industries, including healthcare and marketing, with a commitment to delivering impactful, lasting change while fostering a positive employee experience.

HST is a technology company focused on advancing clean energy solutions and facilitating the development of renewable energy projects. It operates a marketplace that connects clean energy developers with pre-vetted landowners, energy offtakers, and financiers, enabling swift contract execution. By leveraging digital land asset valuation technology and integrated digital services, HST enhances trust with landowners and streamlines the process of securing low-risk land deals. The platform is designed to help developers create de-risked projects that deliver clean energy to communities while accelerating the decarbonization of the energy grid. HST utilizes optimization techniques within its software to minimize the levelized cost of energy, allowing energy traders to effectively identify and bid on competitive projects. Headquartered in the San Francisco Bay Area, HST's team combines extensive experience in clean energy and software development to reshape the future of renewable energy generation.

BioLum Sciences LLC, founded in 2015 and based in Dallas, Texas, focuses on developing innovative asthma management devices that enable patients to monitor airway inflammation. The company specializes in bioanalytical chemistry and medical device development, utilizing a chemiluminescent platform to measure biomarkers in exhaled breath condensate and blood samples. Their primary product, the BioSense Airway Monitoring Device (AMD), allows for at-home monitoring of lung function by measuring oxidative stress biomarkers without complicated breathing maneuvers. This technology not only aids patients in tracking their symptoms and medication efficacy but also provides physicians with vital data to optimize treatment plans. Additionally, BioLum’s blood analysis product offers a simple finger-prick test to assess nitric oxide levels and cardiovascular health. The company's initiatives extend to addressing chronic diseases such as asthma, chronic obstructive pulmonary disease (COPD), hypertension, and heart failure, supporting both clinicians and researchers in personalizing treatment strategies and improving patient outcomes.